HAEMATO AG (HAM:HAEK)

Germany flag Germany · Delayed Price · Currency is EUR
11.30
-0.70 (-5.83%)
At close: Apr 29, 2026
Market Cap59.07M -19.3%
Revenue (ttm)260.81M +2.5%
Net Income9.61M +2,578.0%
EPS1.88 +2,605.8%
Shares Out5.23M
PE Ratio6.03
Forward PEn/a
Dividend0.04 (0.33%)
Ex-Dividend DateJul 16, 2025
Volumen/a
Average Volume562
Open11.30
Previous Close12.00
Day's Range11.30 - 11.30
52-Week Range8.20 - 14.10
Beta0.00
RSI46.26
Earnings Daten/a

About HAEMATO AG

HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. It operates through Specialty Pharma and Lifestyle & Aesthetics segments. The company engages in the development, acquisition, licensing, and distribution of prescription drugs and OTC products, special cosmetics, as well as dietary supplements. In addition, it provides pharmaceuticals in the areas of HIV/AIDS, neurology, oncology, and rheumatology diseases. Further, the company develops, manufactures, and distributes diagnostic tests under the HAEMATO... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 1993
Employees 76
Stock Exchange Hamburg Stock Exchange
Ticker Symbol HAEK
Full Company Profile